Mayo Clinic Cancer Center — Rochester, Minnesota

Public research footprint of Mayo Clinic Cancer Center, compiled from the ClinicalTrials.gov public registry.

596

Registered studies

Active

Recruiting now

507

Completed

Stopped or withdrawn

Most-studied conditions

PDAC · Advanced or Metastatic Renal Cell Carcinoma · High-grade Ta/ T1 Papillary Disease Bladder Cancer · Small Cell Lung Carcinoma

Recently updated registry entries

NCT07104032 — IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… (Recruiting)
NCT07252232 — Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal… (Recruiting)
NCT03970447 — A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Mayo Clinic Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.